Teva Pharma Holdings Limited
Manufacture of pharmaceutical preparations · Castleford
ActiveUnited KingdomIncorporated 2016Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
—
Cash
£36,000
Turnover
—
Profit / loss
£49,365,000
Current assets
£36,000
Creditors < 1 year
£9,000
Equity
£369,793,000
Average employees
Not available
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Equity | £369,793,000 | £370,017,000 |
| Retained earnings | £369,793,000 | £370,017,000 |
| Assets | ||
| Fixed assets | £369,766,000 | £369,990,000 |
| Investments | £369,766,000 | £369,990,000 |
| Current assets | £36,000 | £36,000 |
| Cash at bank | £36,000 | £36,000 |
| Liabilities | ||
| Creditors within one year | £9,000 | £9,000 |
| Net current assets | £27,000 | £27,000 |
| Assets less current liabilities | £369,793,000 | £370,017,000 |
| Profit & loss | ||
| Operating profit | £49,589,000 | £304,786,000 |
| Interest receivable | — | £2,575,000 |
| Interest payable | — | £996,000 |
| Profit before tax | £49,365,000 | £306,365,000 |
| Profit / loss | £49,365,000 | £306,365,000 |
| Dividends | £49,589,000,000 | £330,498,000,000 |
| Operating costs | ||
| Audit fees | £4,000,000 | £7,000,000 |
| People & pay | ||
| Directors' remuneration | £920,000 | £887,000 |
| Highest paid director | £556,000 | £549,000 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Auditor
- Azets Audit Services Limited
- Audit opinion
- Clean (unmodified)
- Immediate parent
- Teva Pharmaceuticals Europe B.V.
- Ultimate parent
- Teva Pharmaceutical Industries Limited
- Ultimate controlling party
- Teva Pharmaceutical Industries Limited
- Accounts
- FRS 102
- Approved
- 2026-09-15, signed by S Charlesworth
Subsidiaries (9)
- Arrow Generics Limited · 100% · United Kingdom · Non-trading company
- Breath Limited · 100% · United Kingdom · License holder company
- Cephalon (UK) Limited · 100% · United Kingdom · Non-trading company
- Norton Healthcare Limited · 100% · United Kingdom · Research, development and manufacture of pharmaceutical products
- Pliva Pharma Limited · 100% · United Kingdom · Non-trading company
- Teva Laboratories UK Limited · 100% · United Kingdom · License holder company
- Teva Pharmaceuticals Limited · 100% · United Kingdom · Non-trading company
- Teva UK Limited · 100% · United Kingdom · Marketing and distribution of pharmaceutical products
- Teva UK Holdings Limited · 100% · United Kingdom · Non-trading company
Share classes (1)
- 1 ordinary shares of £1 each
Events after the year end (1)
- During August 2026, the company paid a dividend of £36,000 to the company’s immediate parent company, Teva Pharmaceuticals Europe B.V.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.